This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (32)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Thrombolysis  • Venous Thromboembolism  • Cardiovascular System  • Review  • Cardiovascular Disease/ Myocardial Infarction  • Alert me on articles by topic  Social Bookmarking   What's this?

From Genes to Treatment

Douglas S. Jacoby, MD; Daniel J. Rader, MD

Arch Intern Med. 2003;163:1155-1164.

The renin-angiotensin system plays a central role in the pathogenesis of cardiovascular disease. At the molecular and cellular levels, angiotensin II, the main effector peptide of the system, stimulates key components of atherosclerosis. Trials in animals and humans indicate that blocking renin-angiotensin system pathways decreases atherosclerotic plaque progression and ischemic events. This review provides a broad overview of the entire role of the renin-angiotensin system in atherothrombotic disease, ranging from molecular pathways to human genetics to the latest clinical trials.

From the Division of Cardiovascular Medicine, Department of Medicine, University of Pennsylvania Health System, Philadelphia. The authors have no relevant financial interest in this article.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Renin-Angiotensin System Haplotypes and the Risk of Myocardial Infarction and Stroke in Pharmacologically Treated Hypertensive Patients
Marciante et al.
Am J Epidemiol 2007;166:19-27.
ABSTRACT | FULL TEXT  

Review: Angiotensin-converting enzyme inhibitors and coronary heart disease prevention
Donnelly and Manning
Journal of Renin-Angiotensin-Aldosterone System 2007;8:13-22.
ABSTRACT  

The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part I: Pathophysiology and Clinical Trial Evidence (Risk Factors Through Stable Coronary Artery Disease)
Dzau et al.
Circulation 2006;114:2850-2870.
FULL TEXT  

Rethinking Primary Prevention of Atherosclerosis-Related Diseases
Napoli et al.
Circulation 2006;114:2517-2527.
FULL TEXT  

RhoA Mediates Angiotensin II-Induced Phospho-Ser536 Nuclear Factor {kappa}B/RelA Subunit Exchange on the Interleukin-6 Promoter in VSMCs
Cui et al.
Circ. Res. 2006;99:723-730.
ABSTRACT | FULL TEXT  

Molecular Dissection of Angiotensin II-Activated Human LOX-1 Promoter
Chen et al.
Arterioscler. Thromb. Vasc. Bio. 2006;26:1163-1168.
ABSTRACT | FULL TEXT  

Aldosterone Promotes Thrombosis Formation After Arterial Injury in Mice
Bodary et al.
Arterioscler. Thromb. Vasc. Bio. 2006;26:233-233.
FULL TEXT  

Atherosclerotic renal artery stenosis, ACE inhibitors, and avoiding cardiovascular death
Main
Heart 2005;91:548-552.
FULL TEXT  

Angiotensin II Amplifies Macrophage-Driven Atherosclerosis
Nobuhiko et al.
Arterioscler. Thromb. Vasc. Bio. 2004;24:2143-2148.
ABSTRACT | FULL TEXT  

Modulation of the renin-angiotensin-aldosterone system for the secondary prevention of stroke
Sokol et al.
Neurology 2004;63:208-213.
ABSTRACT | FULL TEXT  

Role of the Renin-Angiotensin System in the Pathogenesis of Vascular Disease
Carter and Rosencrance
Arch Intern Med 2003;163:2791-2791.
FULL TEXT  

Is Angiotensin Receptor Blockade Antithrombotic?
Lim and Lip
Arch Intern Med 2003;163:2790-2791.
FULL TEXT  

Vascular Protection of ACE Inhibitors
Messerli
Arch Intern Med 2003;163:2791-2792.
FULL TEXT